Impact of High Tibial Osteotomy in Preventing Degenerative Disease Progression in Medial Knee Osteoarthritis.
HTO-IOR
1 other identifier
interventional
50
1 country
1
Brief Summary
High tibial osteotomy (HTO) surgical procedure can lead to clinically significant improvements in the cartilage and in subchondral bone quality, with a slow down of the osteoarthritis (OA) progression. Aim of the project is to: (i) clinically validate a 3D planned HTO surgical approach, through a quantitative grading of OA progression in a prospective randomized case-control clinical trial; (ii) correlate the internal knee loads with the changes assessed in cartilage and subchondral bone status to verify the hypothesis that HTO induced mechanical changes are associated with clinically significant OA improvements; (iii) relate imaging data with cartilage and subchondral bone mechanical properties, in order to classify OA progression in a more sensitive manner and allow a more precise diagnosis of the pathology stage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable knee-osteoarthritis
Started May 2021
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2023
CompletedFirst Submitted
Initial submission to the registry
March 23, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2024
CompletedJanuary 17, 2025
January 1, 2025
1.8 years
March 23, 2023
January 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Cartilage morphology and composition assessment via T1rho and T2 mapping from 3Tesla (3T) magnetic resonance imaging(MRI).
Baseline and one-year follow-up cartilage status will be assessed in order to detect changes in cartilage status after the treatment. Quantitative cartilage assessment will be perfomed using T1rho and T2 mapping sequences which will be gathered during MRI.
3 years
Subchondral bone morphological and structural analysis via Cone Bean Computed Tomography (CBCT) of the knee.
Baseline and one-year follow-up subchondral bone morphological and structural features will be assessed via CBCT analysis, which allow to perform a weight-bearing assessment of the knee bone status and morphology.
3 years
Clinical Score for Knee function 1
Marx Activity Rating Scale (MARS) score is an outcome reporting measure to evaluate the activity level of patients with various knee disorders who participate in sports. The MARS focuses on four activity points: running, deceleration, cutting (changing directions while running) and pivoting. MARS form will be assessed at baseline, six-months and 1-year follow-up. Higher scores mean a better outcome, lower scores mean a worse outcome.
3 years
Clinical Score for Knee function 2
The Knee Injury and Osteoarthritis Outcome score KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. The KOOS meets basic criteria of outcome measures and can be used to evaluate the course of knee injury and treatment outcome. KOOS form will be assessed at baseline, six-months and 1-year follow-up. Higher scores mean a better outcome, lower scores mean a worse outcome.
3 years
Clinical Score for Knee function 3
IKDC Subjective and objective Knee Evaluation Form. The entire IKDC form, which includes a demographic form, current health assessment form, subjective knee evaluation form, knee history form, surgical documentation form, and knee examination form, may be used as separate forms. IKDC evaluation form will be assessed at baseline, six-months and 1-year follow-up. Higher scores mean a better outcome, lower scores mean a worse outcome.
3 years
Secondary Outcomes (3)
Gait analysis assessment
3 years
Scores for general health
3 years
Scores for pain
3 years
Study Arms (2)
surgical
EXPERIMENTALpatients who undergo high tibial osteotomy procedure
conservative
NO INTERVENTIONpatients who undergo conservative treatment
Interventions
Valgus producing Opening wedge high tibial osteotomy will be performed through a medial incision at the proximal tibia and stabilized with a plate and screws. Hardware will be removed within 10-12 months to avoid soft tissue irritation.
Eligibility Criteria
You may qualify if:
- medial knee osteoarthritis in varus knee malalignment (\> 4°)
You may not qualify if:
- Inability to sign informed consent
- joint infection
- inflammatory chronic disease
- previous major surgical procedure of the indexed knee (simple arthroscopy or meniscectomy would be not considered major procedure)
- BMI \> 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stefano Zaffagnini
Bologna, 40135, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2023
First Posted
May 19, 2023
Study Start
May 17, 2021
Primary Completion
March 22, 2023
Study Completion
December 3, 2024
Last Updated
January 17, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share